Hepatitis C virus infection and interferon therapy in patients with Down syndrome

Pediatrics International

Volumn 50, Issue 1, 2008, Pages 7-11

  Miyoshi, Yoko ^a   Tajiri, Hitoshi ^b   Okaniwa, Mariko ^c   Terasawa, Sousuke ^d   Fujisawa, Tomoo ^e   Iizuka, Toshiyuki ^f   Ozono, Keiichi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA GENERAL MEDICAL CENTER   (Japan)

^c MUSASHINO RED CROSS HOSPITAL   (Japan)

^d Gifu Kouseiren General Hospital   (Japan)

^e NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^f TOTTORI UNIVERSITY   (Japan)

Author keywords

Blood transfusion; Down syndrome; Hepatitis C virus; Interferon; Liver disease

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; INTERFERON; LIOTHYRONINE; THYROXINE; VIRUS RNA;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANOREXIA; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FEVER; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER BIOPSY; LIVER DISEASE; MALE; MOUTH DISEASE; NEUTROPENIA; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; SCHOOL CHILD; VIRUS LOAD;

ADOLESCENT; CHILD; DOWN SYNDROME; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; QUESTIONNAIRES;

EID: 39049088652     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2007.02515.x     Document Type: Article

References (28)

1. Tada K, Tajiri H, Kozaiwa K, Sawada A, Guo W, Okada S. Role of screening for hepatitis C virus in children with malignant disease and who undergo bone marrow transplantation. Transfusion 1997 37 : 641 4.
2. Chaudhary RK, Perry E, Hicks F, MacLean C, Morbey M. Hepatitis B. and C infection in an institution for the developmentally handicapped. N. Engl. J. Med. 1992 327 : 1953.
3. Piccione M, De Curtis M, La Vecchia ML, Novissimo A, Vajro P. Hepatitis B. and C infection in children with Down syndrome. Eur. J. Pediatr. 1997 156 : 420 21.
4. Vellinga A, Van Damme P, Meheus A. Hepatitis B. and C in institutions for individuals with intellectual disability. J. Intellect. Disabil. Res. 1999 43 : 445 53.
5. Cuadrado E, Barrena MJ. Immune dysfunction in Down syndrome: Primary immune deficiency or early senescence of the immune system? Clin. Immunol. Immunopathol. 1996 78 : 209 14.
6. Vogt M, Lang T, Frosner G et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N. Engl. J. Med. 1999 341 : 866 70.
7. Davis GL, Balart LA, Schiff ER et al. Treatment of chronic hepatitis C with recombinant interferon alfa: A multicenter randomized, controlled trial. N. Engl. J. Med. 1989 321 : 1501 6.
8. DiBisgeglie AM, Martin P, Kassianides C et al. Recombinant interferon alfa therapy for chronic hepatitis C: A randomized double-blind, placebo-controlled trial. N. Engl. J. Med. 1989 321 : 1506 10.
9. Shindo M, DiBisceglie AM, Hoofnagle JH. Long-term follow-up of patients with chronic hepatitis C treated with alfa-interferon. Hepatology 1992 15 : 1013 16.
10. Hagiwara H, Hayashi N, Ueda K et al. Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-alfa. Hepatology 1992 15 : 37 41.
11. Bortolotti F, Giacchino R, Vajro P et al. Recombinant interferon-alfa therapy in children with chronic hepatitis C. Hepatology 1995 22 : 1623 7.
12. Iorio R, Penstati P, Porzio S, Fariello I, Guida S, Vegnente A. Lymphoblastoid interferon alfa treatment in chronic hepatitis C. Arch. Dis. Child. 1996 74 : 152 6.
13. Sawada A, Tajiri H, Kozaiwa K et al. Favorable response to lymphoblastoid interferon-alpha in children with chronic hepatitis C. J. Hepatol. 1998 28 : 184 8.
14. Okamoto H, Okada S, Sugiyama Y et al. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. J. Exp. Med. 1990 60 : 215 22.
15. Kaneko S, Murakami S, Unoura M, Kobayashi K. Quantitation of hepatitis C virus RNA by competitive polymerase chain reaction. J. Med. Virol. 1992 37 : 278 82.
16. Pawlotsky JM. Use and interpretation of virological tests for hepatitis C. Hepatology 2002 36 : S65 73.
17. Tsukiyama-Kohara K, Yamaguchi K, Maki N et al. Antigenicities of group I and group II hepatitis C virus polypeptides: Molecular basis of diagnosis. Virology 1993 192 : 430 37.
18. Okamoto H, Kobata S, Tokita H et al. A second-generation method of genotyping hepatitis C virus by the polymerase chain reaction with sense and antisense primers deduced from the core gene. J. Virol. Methods 1996 57 : 31 45.
19. Knodell RG, Ishak KG, Black WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981 1 : 431 5.
20. Alter HJ. HCV natural history: The retrospective and prospective in perspective. J. Hepatol. 2005 43 : 550 52.
21. Jara P, Resti M, Hierro L et al. Chronic hepatitis C virus infection in childhood: Clinical patterns and evolution in 224 white children. Clin. Infect. Dis. 2003 36 : 275 80.
22. Jacobson KR, Murray K, Zellos A, Schwarz KB. An analysis of published trials of interferon monotherapy in children with chronic hepatitis C. J. Pediatr. Gastroenterol. Nutr. 2002 34 : 52 8.
23. Colamonici OR, Domanski P. Identification of a novel subunit of the type I interferon receptor localized to human chromosome 21. J. Biol. Chem. 1993 268 : 10 895 9.
24. Mogensen KE, Vignaux F, Gresser I. Enhanced expression of cellular receptors for human interferon alpha on peripheral lymphocytes from patients with Down syndrome. FEBS Lett. 1982 140 : 285 7.
25. Boyer JM, Fontes AK. Proceedings: Interferon levels in Down's syndrome. J. Am. Osteopath. Assoc. 1975 75 : 437 41.
26. Levin S, Schlesinger M, Handzel Z et al. Thymic deficiency in Down syndrome. Pediatrics 1979 63 : 80 87.
27. Hanley JP, Jarvis LM, Andrews J et al. Interferon treatment for chronic hepatitis C interferon in hemophiliacs: Influence of virus load, genotype, and liver pathology on response. Blood 1996 87 : 1704 9.
28. Kim SR, Hayashi Y, Yoon S et al. Prediction of efficacy of interferon treatment of chronic hepatitis C by multivariate analysis and a new classification. Pathol. Int. 1998 48 : 215 20.